Welcome to COMBINE

COMBINE is a five year project which started June 15 2008. COMBINE was initially funded by six Swedish Research organizations, Vinnova, Vårdalstiftelsen, Reumatikerförbundet, Invest in Sweden Agency, KK-stiftelsen, Stiftelsen för strategisk forskning.

The overall objective of COMBINE is to use unique Swedish advantages to improve understanding of why inflammatory diseases develop, what are the most essential goals for patients to achieve, and to develop and implement novelprevention and therapy for these diseases.

COMBINE has enabled a novel participation from patients and patient organizations in design and interpretation of research. It has also - in collaboration with other initiatives - been active in workingwith clinical care for implementation of science in clinical practice. Finally, COMBINE has enabled a novel way for collaboration between translational andclinical science and pharmaceutical/biotech industry.

Some of the major activities and achievements have been summarised in the Combine magazine which was issued June 2012. If you want hard copies of the magazine, please contact Susanne Karlfeldt, +46 (8) 5177 30 24.

To download the Combine magazine, please click here